IntraOp Medical Corporation is pleased to announce its participation as an exhibitor at the European Society for Radiotherapy and Oncology (ESTRO) Annual Congress 2026, taking place May 15–19, 2026, in Stockholm, Sweden.
At ESTRO 2026, IntraOp will showcase the latest advancements in FLASH radiotherapy, with a focus on ongoing and emerging clinical trial progress involving the Mobetron® UHDR system. These innovations are being highlighted in clinical studies including:

IMPulse – Irradiation of Melanoma in a Pulse
LANCE – FLASH Radiotherapy for Skin Cancer

Congress attendees are invited to visit Booth #C05:70 to meet with IntraOp experts, learn more about ultra‑high dose rate (UHDR) electron therapy, and explore how FLASH radiotherapy continues to shape the future of cancer treatment.
IntraOp Medical Corporation looks forward to connecting with clinicians, researchers, and partners in Stockholm and engaging in meaningful conversations around innovation in radiotherapy.